Global Blood Therapeutics Company
GBT is a clinical-stage biopharmaceutical company developing its lead product candidate, voxelotor, as a therapy for sickle cell disease.
Industry:
Small&Large Molecules
Headquarters:
San Francisco, California, United States
Founded Date:
2012
Register and Claim Ownership